• Analyst Research
    • Research Notes
    • Discovery Report
    • CEO Interview
  • News
  • Investor Presentation
  • Sectors
    • Consumer
    • Life Science
    • Telecom
    • Cannabis
    • Technology
    • Mining & Metals
    • Oil & Gas
    • Business Services
  • Contact
  • About
    • Starwood Research Analyst Coverage & Institutional Sponsorship  Services
Starwood Research
  • Analyst Research
    • Research Notes
    • Discovery Report
    • CEO Interview
  • News
  • Investor Presentation
  • Sectors
    • Consumer
    • Life Science
    • Telecom
    • Cannabis
    • Technology
    • Mining & Metals
    • Oil & Gas
    • Business Services
  • Contact
  • About
    • Starwood Research Analyst Coverage & Institutional Sponsorship  Services
News Ticker
  • [ August 2, 2021 ] Tetra Bio-Pharma (OTC: TBPMF): Could This $0.20 stock targeting the $70+ billion pain management market be worth $10.00+ in the next 18 months? Analyst Research
  • [ July 30, 2021 ] Logiq (OTC: LGIQ): Global Ecommerce and Fintech Enabler with 10X Upside Potential Analyst Research
  • [ July 30, 2021 ] Logiq (OTC: LGIQ) Expands Affordable Media Buying to Asia Pacific for Any Size Agency or Brand News
  • [ July 29, 2021 ] Tetra Bio-Pharma (OTC: TBPMF) Files PCT Patent Application for Cannabis Plant Residue News
  • [ July 28, 2021 ] Logiq (OTC: LGIQ) Teams with GumGum to Bring MRC-Accredited Contextual Targeting and Brand Safety to E-Commerce Marketers News
Home2020

Year: 2020

News

NexTech (OTC: NEXCF) Signs Partner Agreement with Jolokia Bringing AR to the Global Learning and Development Industry

January 28, 2020

AR and Interactive Video combine to create world’s most compelling training platform NEW YORK and TORONTO, Jan. 28, 2020– NexTech AR Solutions (the “Company” or “NexTech”) (otcqb:NEXCF) (NTAR)(N29) NexTech AR Solutions, the industry leader in […]

Posts navigation

« 1 … 15 16 17 18 »

Join Our E-Mail Newsletter

News

  • News

    Logiq (OTC: LGIQ) Expands Affordable Media Buying to Asia Pacific for Any Size Agency or Brand

    July 30, 2021
    NEW YORK, July 21, 2021 — Logiq, Inc. (NEO: LGIQ) (OTCQX: LGIQ), a global provider of award-winning e-commerce and fintech solutions, has expanded its Logiq Digital Marketing™ (LDM) platform to include direct media buying access to web, mobile and connected TV (CTV), and audio media providers across the Asia Pacific [...]
  • News

    Tetra Bio-Pharma (OTC: TBPMF) Files PCT Patent Application for Cannabis Plant Residue

    July 29, 2021
    OTTAWA, ON, July 29, 2021  – Tetra Bio-Pharma Inc (“Tetra” or the Company”) (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), a leader in cannabinoid-based drug discovery and development has announced that it filed a PCT patent application for Cannabis Plant Residue and Use Thereof, PCT Patent Application No. PCT/CA2021/050886, with a filing [...]
  • News

    Logiq (OTC: LGIQ) Teams with GumGum to Bring MRC-Accredited Contextual Targeting and Brand Safety to E-Commerce Marketers

    July 28, 2021
    NEW YORK, July 28, 2021  — Logiq, Inc. (NEO: LGIQ) (OTCQX: LGIQ), a global provider of award-winning e-commerce and fintech solutions, has partnered with GumGum, a global media and contextual intelligence company, to provide e-commerce marketers a powerful targeting solution for their digital advertising campaigns. GumGum will offer its contextual intelligence solution, Verity™, [...]
  • News

    Logiq (OTC: LGIQ) Announces Exercise of Over-Allotment Option in Initial Public Offering

    July 27, 2021
    NEW YORK, July 27, 2021 — Logiq, Inc. (“Logiq” or the “Company”) (NEO: LGIQ) (OTCQX: LGIQ), a global provider of award-winning e-commerce and fintech solutions, is pleased to announce the partial exercise of the over-allotment option in conjunction with the Company’s C$5,929,302 initial public offering (the “Offering”) of units of [...]
  • News

    Tetra Bio-Pharma (OTC: TBPMF) Accelerates REBORN1© Trial

    July 12, 2021
    Ethics Committee approves REBORN1© protocol amendment allowing for the addition of two immediate release oral opioids to be compared against QIXLEEF™. REBORN1© is the first of its kind proof-of-concept phase 2 study comparing a cannabinoid-based drug, QIXLEEF™, to immediate release oral opioid for the treatment of breakthrough cancer pain. QIXLEEF™ [...]
  • Legal Notice & Terms of Use

Copyright © 2025 | MH Magazine WordPress Theme by MH Themes